Akebia Therapeutics
AKBA
AKBA
75 hedge funds and large institutions have $30.9M invested in Akebia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
17% less funds holding
Funds holding: 90 → 75 (-15)
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
78% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 32
Holders
75
Holding in Top 10
1
Calls
$400K
Puts
$39K
Top Buyers
| 1 | +$6.02M | |
| 2 | +$767K | |
| 3 | +$296K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$35K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$1.12M | |
| 3 | -$787K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$450K |
| 5 |
Goldman Sachs
New York
|
-$259K |